Reducing Catheter Dependency

The HeRO Graft is a hemodialysis access graft for patients who are failing fistulas or grafts or are catheter-dependent due to the blockage of veins leading to the heart.

HeRO Graft - Hemodialysis Reliable Outflow

Quality of Life

Compared to catheters, HeRO Graft has:

  • 69% fewer infections1
  • 16% to 32% improved dialysis clearance of toxins and fluids (Kt/V)1
  • Less than half the interventions to keep access functioning1
  • Patency rates comparable to AVG2

HeRO Graft (Hemodialysis Reliable Outflow) is the ONLY fully subcutaneous AV access solution clinically proven to maintain long-term access for hemodialysis patients with central venous stenosis. HeRO Graft is classified by the FDA as a graft, but differs from a conventional AV graft since it has no venous anastomosis. It consists of two primary components:

Img1A proprietary ePTFE Arterial Graft Component

The HeRO Graft Arterial Graft Component has a 6mm inner diameter (ID), 7.4mm outer diameter (OD), and is 53cm long, inclusive of the connector. It consists of an ePTFE hemodialysis graft with PTFE beading to provide kink resistance near the proprietary titanium connector. The titanium connector attaches the Arterial Graft Component to the Venous Outflow Component. The Arterial Graft Component is cannulated using standard technique according to KDOQI guidelines.

A proprietary Venous Outflow Component

The HeRO Graft Venous Outflow Component has a 5mm ID, 19F (6.3mm) OD, and is 40cm long. It consists of radiopaque silicone with braided nitinol reinforcement (for kink and crush resistance) and a radiopaque marker band at the distal tip.

See the HeRO Graft Instructions for use.

Is HeRO Graft for you?

The HeRO Graft may be right for you if you are:

  • Catheter-dependent
  • Failing your fistula or graft

Key Benefits:

  • Fewer Infections: 69% reduced infection rate compared with catheters1
  • Superior Dialysis Adequacy: 1.7 Kt/V, a 16% to 32% improvement compared with catheters1
  • High Patency Rates: Up to 87% cumulative patency at 2 years1,2
  • Cost Savings: A 23% average savings per year compared with catheters3

HeRO Graft may be the ideal solution for:

  • Salvaging a failing fistula due to central venous stenosis
  • Salvaging a failing AV graft due to central venous stenosis
  • Converting a catheter-dependent patient
  • Patients unable to achieve blood flow rates prescribed by their Doctor
  • Patients unable to reach target Kt/V clearances during dialysis (KDOQI target clearances, Kt/V=1.4)

View Fullscreen

Catalog NumberExpanded Family Name1SterilizationLatex FreeShipping Box Qty
HERO1001Venous Outflow ComponentETOYes1
HERO1001VOCVenous Outflow ComponentETOYes1
HERO1002Arterial Graft ComponentETOYes1
HERO1003Accessory Component KitETOYes1
HERO1006HeRO AllyETOYes1


  1. Initial Experience and Outcome of a New Hemodialysis Access Device for Catheter-Dependent Patients.Howard E. Katzman, Robert B. McLafferty, John R. Ross, Marc H. Glickman, Eric K. Peden and Jeffrey H. Lawson. JVS, Journal of Vascular Surgery, September 2009 Volume 50, Issue 3, Pages 600-607.e1
  2. Gage et al., EJVES 2012.
  3. Dageforde et al., JSR 2012.